Medicine Information

Affordable Drugs: Saving Money by Splitting Pills


One of the least appreciated cost-savers in medical treatment is the simple act of splitting pills. Suppose you're a U.S. citizen with depression who needs to take Lexapro brand of escitalopram oxalate, a commonly prescribed antidepressant, at a typical starting dose of 10 milligrams (mg) per day. Let's figure out how much your treatment will cost, both by month and by day.

For purposes of illustration I'll use prices shown online at drugstore.com. If you buy thirty Lexapro 10-mg tablets (which is how the prescription is usually written) it will cost you $70.15 per month or $2.34 per day to get treated. But what if you buy Lexapro 20-mg tablets and take a half-pill each day? Medically, this treatment is the same. But look what happens to unit prices. Thirty Lexapro 20-mg tablets cost $69.99. We need just 10 mg per day, so we split the 20-mg tablets in half to make our 10-mg doses. (The tablets are even scored to make this easy.) In this case it costs you just $35.00 per month or $1.17 per day to get treated. Your daily price just dropped by half!

Isn't that amazing? And it's not just an isolated example. If you do a similar analysis for many other drugs, you'll find that taking half of a double-strength pill costs substantially less than taking all of a regular-strength pill. Or another way of saying this is that the cost of a month's treatment is driven more by the number of pills involved than by the total number of milligrams taken.

Is this an accident of pricing? Should we be whispering about this? Is this pulling something over on the drug companies? Hardly. If you think that multi-billion-dollar companies trading on the New York Stock Exchange make pricing mistakes, then I've got some choice swamp-land in Florida I'd love to sell you.

So why would drug companies create these pricing mismatches (read: opportunities)? To understand this, let's walk through two prescribing scenarios. First, suppose a doctor is prescribing Lexapro to a patient who is lucky enough to have drug insurance. The patient pays a predetermined co-payment for each month's worth of medication, so he or she has the exact same out-of-pocket expense whichever way the prescription is written. So will the doctor write for thirty 10-mg pills or fifteen 20-mg pills?

Your guess is probably right-the prescription will be written for the larger number of lower-strength pills. The retailer and the drug company will get full price. They're happy. The patient doesn't need to break tablets in half and the doctor doesn't need to take time to explain why pills have to be broken, so they're happy. What's not to like? The only loser is the insurance company. Do the doctor or the patient care? (Let's see, how many favors has the insurance company done for the doctor and patient lately?)

Now here's the second prescribing scenario. Joe Workingman has no drug insurance and has to shell out cash to pay for the full price of medication. The doctor feels that 10 mg daily of Lexapro is needed. This time, the doctor prescribes fifteen Lexapro 20-mg pills per month, instructing the patient to take a half-pill per day. Medically, there is no loss of efficacy. The patient is pleased to pay less money. The doctor is a hero for being thoughtful and clever. Because the doctor still prescribed the same product, the drug company is happy. (The drug company would rather get half their price than nothing. Besides, they've already priced this scenario into their drug.)

So the drug company wins either way, particularly if they're competing against a similar product made by another company that the doctor might choose instead. In fact, all it takes for everyone to be happy is a breakable tablet. Admittedly, some pills are difficult to break in half (but not excessively difficult, or else the drug company wouldn't capture the low-end market). This is where pill-cutters come in handy. Every drugstore has them. They're cheap because they're made out of nothing more than plastic and razor blades. They're better at splitting pills than your thumbs or a paring-knife because they break pills more evenly, and the pieces don't go skittering across the counter.

In the author's practice there are some pill-splitting overachievers who even manage to break quadruple-strength pills into quarters. Imagine the savings in doing that.

In fact, the only obstacle to saving the patient money is if the drug company puts their product into capsules, because capsules can't be split. Would a drug company do such a mean-spirited thing? You betcha.

Lexapro was the sixth so-called serotonin-reuptake-blocker to come on the market, so it had to compete with all the earlier drugs in its class. But the first serotonin-reuptake-blocker to come on the market had first-mover advantage and was able to retain market-share even after the competing products arrived. This first-mover was the world-famous Prozac brand of fluoxetine, made by the Eli Lilly Company.

So what did Lilly do after competing products appeared? They stone-walled the consumer by never ever putting their product into anything other than a capsule. Moreover, for the entire time their product was still patent-protected, they never produced a higher-strength capsule. So if you needed a higher dose of Prozac, you had the honor of paying for two or three capsules per day. Why did they choose such a consumer-unfriendly approach? Because they could. (Everyone now turn toward Indianapolis and wave to the nice people at Lilly.)

My medical students look at me strangely when I start talking about publicly traded companies and market forces while I'm supposed to be teaching them about medicine. But the way I look at it, if you don't understand market forces, then you'll never understand why things in medicine are the way they are.

(C) 2005 by Gary Cordingley

Gary Cordingley, MD, PhD, is a clinical neurologist, teacher and researcher who works in Athens, Ohio. For more health-related articles see his website at: http://www.cordingleyneurology.com


MORE RESOURCES:

National Ledger

Are Your Kids in Danger: Cold Medicine Recall Request by Some Doctors
National Ledger, AZ - 12 hours ago
As parents deal with all of the information and counter information about cold medicine and kids we can now toss another request into the mix. ...
Video: Cold Meds Under Fire, Again CBS
Children's Cough Medicine Recall Requested By Physicians Post Chronicle
FDA Mulls Limits on Kids' Cough Medicine WebMD
MarketWatch - CNNMoney.com
all 782 news articles


The Plain Dealer - cleveland.com

Publication in Annals of Internal Medicine Highlights Clinical ...
WELT ONLINE, Germany - 4 hours ago
EXACT Sciences Corporation (NASDAQ: EXAS) today announced the publication in the Annals of Internal Medicine the findings of a National Institutes of ...
Annals of Internal Medicine tip sheet for Oct.7, 2008, issue EurekAlert (press release)
Task force: Colon cancer screenings can stop at 75 The Associated Press
Screening for Colorectal Cancer: US Preventive Services Task Force ... Annals of Internal Medicine
MarketWatch - The Plain Dealer - cleveland.com
all 226 news articles


US Preventive Medicine: Economic Crisis Creates Opportunity in ...
MarketWatch - 10 hours ago
During this downturn, companies generating double or triple digit annualized growth trends, such as US Preventive Medicine, could be regarded as safe havens ...


Academic Medicine Means Business for Ohio: $37.2 Billion Economic ...
MarketWatch - 17 hours ago
Quantifying academic medicine's economic impact in areas ranging from tax revenue to job creation, the report underscores the significant role Ohio's seven ...
UC College of Medicine generates $4.8 billion in economic impact Bizjournals.com
Health network's impact: $4.8 billion Cincinnati.com
Claiborne hospital receives USDA grant Knoxville News Sentinel
Bizjournals.com
all 21 news articles


Calgary Herald

Nobel medicine prize reopens old AIDS wounds
Reuters South Africa, South Africa - 6 hours ago
By Maggie Fox, Health and Science Editor WASHINGTON, Oct 6 (Reuters) - The decision on Monday to award the Nobel Prize for Medicine to Luc Montagnier and ...
European Researchers Win Nobels for Medicine Washington Post
Three Europeans Win the 2008 Nobel for Medicine New York Times
Noble Medicine Forbes
International Herald Tribune - CNN
all 1,031 news articles


Special Broadcasting Service

Medicine award kicks off Nobel Prize announcements
The Associated Press - 18 hours ago
Only seven women have won the medicine prize since the first Nobel Prizes were handed out in 1901. The last female winner was US researcher Linda Buck in ...
The Nobel Prize TIME
all 232 news articles


The Center for Sleep Medicine receives program reaccreditation
Hattiesburg American, MS - 1 hour ago
The Center for Sleep Medicine at Hattiesburg Clinic recently received program reaccreditation from the American Academy of Sleep Medicine. ...
Hattiesburg Clinic Ophthalmologist receives recertification Hattiesburg American
all 2 news articles


Three Europeans win the 2008 Nobel for medicine
International Herald Tribune, France - 18 minutes ago
By Lawrence K. Altman The Nobel Prize in Medicine was awarded Monday to three European scientists who discovered viruses behind two devastating illnesses, ...


Bolivia tries to bolster public health with traditional medicine
Scientific American - 2 hours ago
The US has a decidedly ambivalent relationship with alternative medicine, though large numbers of Americans routinely ingest nostrums from ginkgo to garlic. ...


Hospital ushers in new sports medicine program
Effingham Herald, GA - 4 hours ago
Effingham Hospital sponsored Effingham Hospital Sports Medicine Night at Rebel Field on Sept. 26, just before the football game between South Effingham High ...

Medicine - Google News

home | site map | Dr. Thad Thomas
© 2006